Naltrexone Effects on Short-Term and Long-Term Smoking Cessation
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: This study examined the efficacy of naltrexone, a long-acting opiate antagonist, as a smoking cessation aid in a double-blind placebo-controlled randomized trial. It was hypothesized that naltrexone would result in higher quit rates at the end of treatment and six months later. METHODS: Subjects were 68 smokers aged 18 to 65 who smoked at least 20 cigarettes daily and wished to stop smoking. They took naltrexone or placebo daily for four weeks and were seen weekly for individual smoking cessation therapy. RESULTS: A statistical trend towards a higher overall cessation rate (cotinine < 15 ng/mL) at end-of-treatment was observed among subjects treated with naltrexone than placebo (46.7% vs. 26.3%, respectively, odds ratio = 2.5, p < .10); however, this difference was attenuated at six months (27% vs. 15%, respectively, odds ratio = 1.9, p = ns). Stratified analysis indicated the usefulness of naltrexone primarily for female smokers and those with a history of major depression. These effects remained six months later. CONCLUSION: These results provide, at best, mild promise for naltrexone as a smoking cessation drug and provide another instance of a differential response to nicotine dependence treatment according to gender and depression history.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signs and Symptoms of Tobacco Withdrawal
Hughes, J. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800030107013 · Cited by 1,669
Naloxone reduces cigarette smoking
Karras, A., & Kane, J. M. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90562-7 · Cited by 144
Heavy Smokers, Smoking Cessation, and Clonidine: Results of a Double-blind, Randomized Trial
Glassman, A. H. (1988) · JAMA · doi:10.1001/jama.1988.03720190031026
Self-citation
Cited by
Smoking Cessation in Women: Special Considerations
Perkins, K. A. (2001) · CNS Drugs · doi:10.2165/00023210-200115050-00005 · Cited by 407
Neurobiology of the nicotine withdrawal syndrome
Kenny, P. J., & Markou, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00651-7 · Cited by 310
Psychiatric disorders and stages of smoking
Breslau, N., Novak, S. P., & Kessler, R. C. (2004) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00317-2 · Cited by 274
History of depression and smoking cessation outcome: A meta-analysis.
Hitsman, B., Borrelli, B., McChargue, D. E., Spring, B., & Niaura, R. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.4.657 · Cited by 253
“In a study by Covey et al. (1999), women with recurrent depression, but not men, were at increased risk for relapse.”
InfluentialDiFranza, J., & Wellman, R. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200412331328538 · Cited by 190
Metadata
- Authors
- Covey, L. S., Glassman, A. H., & Stetner, F.
- Venue
- Journal of Addictive Diseases
- Publisher
- Informa UK Limited
- Published
- 1999-03-31
- Volume
- 18
- Issue
- 1
- Pages
- 31-40
- ISSN
- 1055-0887 (ISSN-L)
- 1545-0848
- OpenAlex
- W1983860141
- Cited by
- 111
- References
- 3
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.